查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1727993

美国医药低温运输包装市场规模、份额、趋势分析报告：按包装类型、基材、温度要求、产品、组件、应用、细分预测，2025-2030 年

U.S. Pharmaceutical Cold Chain Packaging Market Size, Share & Trends Analysis Report By Packaging Format, By Substrate, By Temperature Requirement, By Product, By Component, By Application, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

美国医药低温运输包装市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，美国医药低温运输包装市场规模预计到2030年将达到27.8亿美元，2025年至2030年期间的复合年增长率为14.6%。

这是由于温度敏感药物、疫苗和生技药品的生产和分销增加所致。生物製药、个人化医疗以及细胞和基因疗法的进步推动了对能够在储存和运输过程中保持精确温度条件的专用低温运输解决方案的需求。此外，电子商务药品分销的不断增长、严格的监管要求以及对永续性的日益关注进一步推动了医药低温运输包装和物流市场的成长。

製药业正在向生物製药转变，包括单株抗体、重组蛋白和mRNA疫苗。这些生技药品需要严格的温度控制来维持效力和效果。大多数生技药品在运送过程中需要冷藏（2°C 至 8°C）、冷冻（-20°C）或超冷藏（-80°C 或更低）。此类高价值医药产品的日益普及导致对低温运输基础设施的投资增加，包括隔热包装、即时监控系统和温控储存设施。

例如，基于mRNA的新冠疫苗的成功凸显了超低温低温运输物流的需求，促使企业扩大冷藏能力并投资于创新包装解决方案。生技药品在癌症、自体免疫疾病和罕见疾病治疗中的持续增长预计将使对先进医药低温运输解决方案的需求保持在高位。

此外，细胞和基因治疗市场正在迅速扩张，美国在临床试验和商业发布方面处于领先地位。这些创新治疗方法包含活细胞和遗传物质，需要低温储存（低于-150°C）才能保持活力。 CAR-T细胞疗法、干细胞疗法和基因编辑技术需要专门的低温运输物流来确保从製造到患者管理的产品完整性。

随着FDA核准的个人化治疗数量不断增加，迫切需要基于液态氮的低温储存解决方案、有效的绝缘包装和准确的追踪系统。低温运输物流供应商正在投资专用冷冻库、低温运输机和智慧追踪解决方案，以满足对这些高度敏感的治疗剂日益增长的需求。

许多患者，尤其是患有慢性疾病的患者，现在透过邮购药局或订阅式药物配送服务来获得药物。这种转变推动了对紧凑、经济高效的绝缘包装解决方案的需求，这些解决方案可以在最后一英里的运送过程中保持温度稳定。

领先的製药公司和物流供应商正在扩大其低温运输配送网络，以确保及时、温控配送。隔热邮件、冷藏运输卡车和支援物联网的追踪设备正在被广泛采用，以满足对温度敏感的药品运输日益增长的需求。

美国医药低温运输包装市场报告重点

  • 预计到 2024 年，发泡聚苯乙烯 (EPS) 基材部分将占据最大的市场收益占有率，超过 15.2%。发泡聚苯乙烯 (EPS) 基材因其出色的绝缘性能、轻质结构、成本效益和易于定製而占据市场主导地位。
  • 盒装产品领域在 2024 年占据了最大的市场收益占有率，超过 51.6%，这得益于其提供可靠绝缘、易于操作、成本效益高以及在整个医药供应链中广泛使用等卓越能力。
  • 绝缘组件部门在 2024 年占据最大的市场收益占有率，超过 73.9%。在疫苗、生技药品、胰岛素和特殊药物等对温度敏感的药品的运输和储存过程中，隔热材料对于维持所需的温度范围起着关键作用。
  • 美国医药低温运输包装产业竞争激烈，主要企业不断创新，以满足对温度敏感的医药产品运输日益增长的需求。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国医药低温运输包装市场变数、趋势与范围

  • 市场展望
  • 渗透和成长前景图
  • 产业价值链分析
  • 科技趋势
  • 法律规范
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 商业环境分析
    • 波特五力分析
    • PESTEL分析

第四章：美国医药低温运输包装市场：依包装类型估价与趋势分析

  • 关键要点
  • 2024年及2030年包装形式趋势分析及市场占有率
    • 积极的
    • 被动的

第五章美国医药低温运输包装市场：按温度要求的估计和趋势分析

  • 关键要点
  • 2024年及2030年包装形式趋势分析及市场占有率
    • 室温控制（15℃~25℃）
    • 冷藏（2℃至8℃）
    • 冷冻（0℃以下）
    • 冷冻（-20℃至-40℃）
    • 极低温（-150℃以下）

第六章美国医药低温运输包装市场：依基材的估计与趋势分析

  • 关键要点
  • 2024年及2030年基材趋势分析及市场占有率
    • 聚乙烯（PE）
    • 聚丙烯（PP）
    • 聚对苯二甲酸乙二醇酯（PET）
    • 发泡聚苯乙烯（EPS）
    • 聚氨酯（PU）
    • 真空绝热板（VIP）
    • 隔热包装（TIP）
    • 金属
    • 其他的

第七章美国医药低温运输包装市场：按产品分類的估计和趋势分析

  • 关键要点
  • 2024 年及 2030 年产品趋势分析及市场占有率
    • 盒子
    • 梅勒
    • 调色盘
    • 其他的

第八章美国医药低温运输包装市场：按组成部分的估计和趋势分析

  • 关键要点
  • 2024 年和 2030 年各组件的市场占有率
    • 冷却液
    • 绝缘

第九章：美国医药低温运输包装市场：按应用的估计和趋势分析

  • 关键要点
  • 2024 年及 2030 年各应用领域的趋势分析及市场占有率
    • 生物製药公司
    • 临床研究所
    • 医院
    • 研究机构
    • 物流配送公司
    • 其他的

第十章 竞争格局

  • 全球主要参与者和最新趋势及其对该行业的影响
  • 公司/竞争对手分类
  • 供应商格局
    • 原物料供应商名单
  • 企业市场分析
  • 公司热图分析
  • Company Dashboard Analysis
  • 战略地图
    • 扩张
    • 合併与收购
    • 合作/伙伴关係/协议
    • 新产品发布
    • 其他的

第十一章 公司列表（概述、财务表现、产品概述）

  • Insulated Products Corporation
    • 公司简介
    • 财务表现
    • 产品基准
  • Sealed Air
  • Peli BioThermal Limited
  • CSafe
  • Intelsius
  • Sonoco ThermoSafe
  • Cryoport Systems, LLC
  • SkyCell AG
  • Inmark Global Holdings, LLC
  • Smurfit Kappa
Product Code: GVR-4-68040-548-3

U.S. Pharmaceutical Cold Chain Packaging Market Growth & Trends:

The U.S. pharmaceutical cold chain packaging market size is anticipated to reach USD 2.78 billion by 2030 and is projected to grow at a CAGR of 14.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. This is due to the increasing production and distribution of temperature-sensitive drugs, vaccines, and biologics. With advancements in biopharmaceuticals, personalized medicine, and cell & gene therapies, there is a rising need for specialized cold chain solutions that can maintain precise temperature conditions throughout storage and transportation. In addition, the expansion of e-commerce-based drug distribution, stringent regulatory requirements, and a growing focus on sustainability are further driving the market growth for pharmaceutical cold chain packaging and logistics.

The pharmaceutical industry is shifting toward biopharmaceuticals, which include monoclonal antibodies, recombinant proteins, and mRNA vaccines. These biologics require strict temperature control to maintain their potency and efficacy. Most biologics need cold storage (2°C to 8°C), frozen storage (-20°C), or ultra-cold storage (-80°C or lower) during transportation. The rising adoption of these high-value drugs has led to increased investment in cold chain infrastructure, including insulated packaging, real-time monitoring systems, and temperature-controlled storage facilities.

For instance, the success of mRNA-based COVID-19 vaccines highlighted the necessity for ultra-cold chain logistics, prompting companies to expand their cold storage capabilities and invest in innovative packaging solutions. With the continued growth of biologics in treating cancer, autoimmune diseases, and rare disorders, the demand for advanced pharmaceutical cold chain solutions is expected to remain high.

Moreover, the cell & gene therapy market is rapidly expanding, with the U.S. leading in clinical trials and commercial launches. These innovative therapies involve living cells and genetic material, requiring cryogenic storage (-150°C or lower) to preserve viability. CAR-T cell therapies, stem cell treatments, and gene-editing technologies demand specialized cold chain logistics to ensure product integrity from the point of manufacturing to patient administration.

With the rising number of FDA approvals for personalized therapies, there is an urgent need for liquid nitrogen-based cryogenic storage solutions, validated insulated packaging, and precise tracking systems. Cold chain logistics providers are investing in specialized freezers, cryogenic shippers, and smart tracking solutions to support the growing demand for these highly sensitive treatments.

The rise of online pharmacies and direct-to-patient drug delivery is another key factor fueling the demand for pharmaceutical cold chain logistics in the U.S. Many patients, especially those with chronic conditions, now receive medications via mail-order pharmacies and subscription-based drug delivery services. This shift has increased the need for compact, cost-efficient, and insulated packaging solutions that can maintain temperature stability during last-mile distribution.

Leading pharmaceutical companies and logistics providers are expanding cold chain distribution networks to ensure timely and temperature-controlled deliveries. Insulated mailers, refrigerated delivery trucks, and IoT-enabled tracking devices are being widely adopted to support the growing demand for temperature-sensitive drug distribution.

U.S. Pharmaceutical Cold Chain Packaging Market Report Highlights:

  • The Expanded Polystyrene (EPS) substrate segment recorded the largest market revenue share of over 15.2% in 2024. Expanded Polystyrene (EPS) substrate is dominating the market due to its superior insulating properties, lightweight structure, cost-effectiveness, and ease of customization.
  • The boxes product segment recorded the largest market revenue share of over 51.6% in 2024 due to its superior ability to provide reliable thermal insulation, ease of handling, cost-effectiveness, and widespread use across the pharmaceutical supply chain.
  • The insulation component segment recorded the largest market revenue share of over 73.9% in 2024. Insulation materials play a critical role in maintaining the required temperature range for temperature-sensitive pharmaceuticals such as vaccines, biologics, insulin, and specialty drugs during transportation and storage.
  • The U.S. pharmaceutical cold chain packaging industry is highly competitive, with key players continuously innovating to meet the growing demand for temperature-sensitive drug transportation.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Research Methodology
    • 1.1.1. Market Segmentation
    • 1.1.2. Market Definition
  • 1.2. Research Scope & Assumptions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot, 2024 (USD Million)
  • 2.2. Segmental Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Pharmaceutical Cold Chain Packaging Market Variables, Trends, and Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
  • 3.4. Technology Trends
  • 3.5. Regulatory Framework
  • 3.6. Market Dynamics
    • 3.6.1. Market Driver Analysis
    • 3.6.2. Market Restraint Analysis
    • 3.6.3. Market Opportunity Analysis
    • 3.6.4. Market Challenge Analysis
  • 3.7. Business Environment Analysis
    • 3.7.1. Porter's Five Forces Analysis
    • 3.7.2. PESTEL Analysis

Chapter 4. U.S. Pharmaceutical Cold Chain Packaging Market: Packaging Format Estimates & Trend Analysis

  • 4.1. Key Takeaways
  • 4.2. Packaging Format Movement Analysis & Market Share, 2024 & 2030
    • 4.2.1. Active
      • 4.2.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. Passive
      • 4.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Pharmaceutical Cold Chain Packaging Market: Temperature Requirement Estimates & Trend Analysis

  • 5.1. Key Takeaways
  • 5.2. Packaging Format Movement Analysis & Market Share, 2024 & 2030
    • 5.2.1. Controlled Room Temperature (15°C - 25°C)
      • 5.2.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.2.2. Refrigerated (2°C - 8°C)
      • 5.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.2.3. Frozen (0°C and below)
      • 5.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.2.4. Deep-Frozen (-20°C to -40°C)
      • 5.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.2.5. Cryogenic (-150°C and below)
      • 5.2.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Pharmaceutical Cold Chain Packaging Market: Substrate Estimates & Trend Analysis

  • 6.1. Key Takeaways
  • 6.2. Substrate Movement Analysis & Market Share, 2024 & 2030
    • 6.2.1. Polyethylene (PE)
      • 6.2.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. Polypropylene (PP)
      • 6.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Polyethylene Terephthalate (PET)
      • 6.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Expanded Polystyrene (EPS)
      • 6.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.5. Polyurethane (PU)
      • 6.2.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.6. Vacuum Insulated Panel (VIP)
      • 6.2.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.7. Temperature Insulated Packaging (TIP)
      • 6.2.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.8. Metal
      • 6.2.8.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.9. Others
      • 6.2.9.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Pharmaceutical Cold Chain Packaging Market: Product Estimates & Trend Analysis

  • 7.1. Key Takeaways
  • 7.2. Product Movement Analysis & Market Share, 2024 & 2030
    • 7.2.1. Boxes
      • 7.2.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. Mailers
      • 7.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Pallets
      • 7.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Others
      • 7.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. U.S. Pharmaceutical Cold Chain Packaging Market: Component Estimates & Trend Analysis

  • 8.1. Key Takeaways
  • 8.2. Component Movement Analysis & Market Share, 2024 & 2030
    • 8.2.1. Coolant
      • 8.2.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. Insulation
      • 8.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. U.S. Pharmaceutical Cold Chain Packaging Market: Application Estimates & Trend Analysis

  • 9.1. Key Takeaways
  • 9.2. Application Movement Analysis & Market Share, 2024 & 2030
    • 9.2.1. Biopharmaceutical Companies
      • 9.2.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.2.2. Clinical Research Organizations
      • 9.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.2.3. Hospitals
      • 9.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.2.4. Research Institutes
      • 9.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.2.5. Logistics and Distribution Companies
      • 9.2.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.2.6. Others
      • 9.2.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Key Global Players & Recent Developments & Their Impact on the Industry
  • 10.2. Company/Competition Categorization
  • 10.3. Vendor Landscape
    • 10.3.1. List of Raw Material Suppliers
  • 10.4. Company Market Position Analysis
  • 10.5. Company Heat Map Analysis
  • 10.6. Company Dashboard Analysis
  • 10.7. Strategy Mapping
    • 10.7.1. Expansions
    • 10.7.2. Mergers & Acquisitions
    • 10.7.3. Collaborations/Partnerships/Agreements
    • 10.7.4. New Product Launches
    • 10.7.5. Others

Chapter 11. Company Listing (Overview, Financial Performance, Products Overview)

  • 11.1. Insulated Products Corporation
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
  • 11.2. Sealed Air
  • 11.3. Peli BioThermal Limited
  • 11.4. CSafe
  • 11.5. Intelsius
  • 11.6. Sonoco ThermoSafe
  • 11.7. Cryoport Systems, LLC
  • 11.8. SkyCell AG
  • 11.9. Inmark Global Holdings, LLC
  • 11.10. Smurfit Kappa

List of Tables

  • Table 1. U.S. Pharmaceutical Cold Chain Packaging market estimates and forecasts, by Packaging Format, 2018 - 2030 (USD Million)
  • Table 2. U.S. Pharmaceutical Cold Chain Packaging market estimates and forecasts, by Temperature Requirement, 2018 - 2030 (USD Million)
  • Table 3. U.S. Pharmaceutical Cold Chain Packaging market estimates and forecasts, by Substrate, 2018 - 2030 (USD Million)
  • Table 4. U.S. Pharmaceutical Cold Chain Packaging market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
  • Table 5. U.S. Pharmaceutical Cold Chain Packaging market estimates and forecasts, by Component, 2018 - 2030 (USD Million)
  • Table 6. U.S. Pharmaceutical Cold Chain Packaging market estimates and forecasts, by Application, 2018 - 2030 (USD Million)

List of Figures

  • 1. Information Procurement
  • 2. Primary Research Pattern
  • 3. Primary Research Process
  • 4. Market Research Approaches - Bottom-Up Approach
  • 5. Market Research Approaches - Top-Down Approach
  • 6. Market Research Approaches - Combined Approach
  • 7. Market Snapshot
  • 8. Segment Snapshot (1/2)
  • 9. U.S. Pharmaceutical Cold Chain Packaging Market - Segment Snapshot (2/2)
  • 10. U.S. Pharmaceutical Cold Chain Packaging Market - Competitive Landscape Snapshot
  • 11. U.S. Pharmaceutical Cold Chain Packaging Market: Penetration & Growth Prospect Mapping
  • 12. U.S. Pharmaceutical Cold Chain Packaging Market: Value Chain Analysis
  • 13. U.S. Pharmaceutical Cold Chain Packaging Market: Porter's Five Force Analysis
  • 14. U.S. Pharmaceutical Cold Chain Packaging Market: PESTEL Analysis
  • 15. U.S. Pharmaceutical Cold Chain Packaging Market: Packaging Format Movement Analysis, 2024 & 2030
  • 16. U.S. Pharmaceutical Cold Chain Packaging Market: Temperature Requirement Movement Analysis, 2024 & 2030
  • 17. U.S. Pharmaceutical Cold Chain Packaging Market: Substrate Movement Analysis, 2024 & 2030
  • 18. U.S. Pharmaceutical Cold Chain Packaging Market: Component Movement Analysis, 2024 & 2030
  • 19. U.S. Pharmaceutical Cold Chain Packaging Market: Product Movement Analysis, 2024 & 2030
  • 20. U.S. Pharmaceutical Cold Chain Packaging Market: Application Movement Analysis, 2024 & 2030
  • 21. U.S. Pharmaceutical Cold Chain Packaging Market: Company Positioning Analysis
  • 22. U.S. Pharmaceutical Cold Chain Packaging Market: Market Dashboard Analysis
  • 23. U.S. Pharmaceutical Cold Chain Packaging Market: Strategy Mapping